GIM
PLRX icon

Granahan Investment Management’s Pliant Therapeutics PLRX Stock Holding History

Granahan Investment Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-527,147
Closed -$6.94M – 182
2024
Q4 		$6.94M Sell
527,147
-211,105
-29% -$2.88M 0.29% 88
2024
Q3 		$8.28M Sell
738,252
-243,797
-25% -$3.05M 0.33% 93
2024
Q2 		$10.6M Sell
982,049
-64,796
-6% -$835K 0.42% 77
2024
Q1 		$15.6M Sell
1,046,845
-103,921
-9% -$1.71M 0.55% 59
2023
Q4 		$20.8M Buy
1,150,766
+211,557
+23% +$3.22M 0.69% 45
2023
Q3 		$16.3M Buy
939,209
+128,852
+16% +$2.23M 0.58% 51
2023
Q2 		$14.7M Buy
810,357
+291,392
+56% +$6.9M 0.45% 65
2023
Q1 		$13.8M Buy
518,965
+13,781
+3% +$392K 0.42% 71
2022
Q4 		$9.77M Buy
505,184
+124,091
+33% +$2.59M 0.3% 93
2022
Q3 		$7.96M Sell
381,093
-148,718
-28% -$2.85M 0.26% 102
2022
Q2 		$4.24M Buy
529,811
+40,477
+8% +$259K 0.14% 127
2022
Q1 		$3.43M Buy
489,334
+216,149
+79% +$2.21M 0.09% 151
2021
Q4 		$3.69M Buy
+273,185
New +$4.34M 0.08% 163

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Granahan Investment Management's PLRX Position: Q1 2025 in Review

Granahan Investment Management sold out of Pliant Therapeutics (PLRX) in Q1 2025, closing a stake of 527,147 shares — an estimated $6.94M sold.

Granahan Investment Management first reported a position in PLRX in Q4 2021 and held it in 13 quarters. The position peaked at $20.8M in Q4 2023. 140 funds tracked by Wall St. Rank hold PLRX as of Q1 2025.

  • Granahan Investment Management reported no remaining Pliant Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Granahan Investment Management sold 527,147 Pliant Therapeutics shares in Q1 2025, an estimated $6.94M.
  • Granahan Investment Management first reported a position in Pliant Therapeutics in Q4 2021 and held it in 13 quarters.
  • Granahan Investment Management's Pliant Therapeutics position peaked at $20.8M in Q4 2023.
  • 140 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2025.

Based on Granahan Investment Management's 13F filing for Q1 2025, filed 15 May 2025.